Zenouzi, R., Liwinski, T., Yamamura, J., Weiler‐Normann, C., Sebode, M., Keller, S., . . . (IPSCSG), t. I. P. S. G. (2018). Follow‐up magnetic resonance imaging/3D‐magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: Challenging for experts to interpret. Alimentary Pharmacology & Therapeutics, 48(2), 169. https://doi.org/10.1111/apt.14797
Chicago Style (17th ed.) CitationZenouzi, R., T. Liwinski, J. Yamamura, C. Weiler‐Normann, M. Sebode, S. Keller, A. W. Lohse, C. Schramm, and the International PSC Study Group (IPSCSG). "Follow‐up Magnetic Resonance Imaging/3D‐magnetic Resonance Cholangiopancreatography in Patients with Primary Sclerosing Cholangitis: Challenging for Experts to Interpret." Alimentary Pharmacology & Therapeutics 48, no. 2 (2018): 169. https://doi.org/10.1111/apt.14797.
MLA (9th ed.) CitationZenouzi, R., et al. "Follow‐up Magnetic Resonance Imaging/3D‐magnetic Resonance Cholangiopancreatography in Patients with Primary Sclerosing Cholangitis: Challenging for Experts to Interpret." Alimentary Pharmacology & Therapeutics, vol. 48, no. 2, 2018, p. 169, https://doi.org/10.1111/apt.14797.